Lykos, the developer of the MDMA-assisted therapy for PTSD, called the FDA's request for more phase 3 research "deeply disappointing."
The unapproved products can cause severe chemical burns and disfiguration when not used under proper supervision.
The FDA has warned consumers about at least 10 lead-contaminated cinnamon products sold in the U.S. over the past year.
